Amo Whitestar Signature Phacoemulsification System
by Abbott Medical Optics, Inc.
510(k) K111697
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK111697 | Date27 Sep 2011 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HQC
- Device Class
- Class II
- Regulation
- 21 CFR Part 886.4670
- Advisory Committee
- Ophthalmic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
The Amo Whitestar Signature Phacoemulsification System is a phacoemulsification system, which is a type of unit used for phacofragmentation. It is used in ophthalmic procedures.
The system is supplied as a modular device and is intended for use in anterior segment surgical procedures, such as cataract removal. It has been cleared by the FDA and has a product code of HQC, with a regulation number of 886.4670.
Other devices from Abbott Medical Optics, Inc.
Questions
AI-generated answers, 6 Oct 2026
What is the Amo Whitestar Signature Phacoemulsification System used for?
The Amo Whitestar Signature Phacoemulsification System is used for cataract removal in ophthalmic procedures, specifically for anterior segment surgical procedures.
Is the Amo Whitestar Signature Phacoemulsification System supplied as a single unit or modular device?
The system is supplied as a modular device, allowing for flexibility and customization in ophthalmic procedures.
What is the regulatory status of the Amo Whitestar Signature Phacoemulsification System?
The Amo Whitestar Signature Phacoemulsification System has been cleared by the FDA, with a product code of HQC and regulation number of 886.4670.